Ascentage Pharma Group International (HKG:6855)
Hong Kong · Delayed Price · Currency is HKD 32.70
+0.78 (2.44%)
Jun 18, 2026, 4:08 PM HKT
HKG:6855 Market Cap
HKG:6855 has a market cap or net worth of 11.75 billion as of June 18, 2026. Its market cap has decreased by -29.75% in one year.
Market Cap
11.75B
Enterprise Value
11.21B
Revenue
638.89M
Ranking
n/a
PE Ratio
n/a
Stock Price
32.70
Market Cap Chart
Since October 28, 2019, HKG:6855's market cap has increased from 7.59B to 11.75B, an increase of 54.84%. That is a compound annual growth rate of 6.80%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 17, 2026 | 11.75B | -38.91% |
| Dec 31, 2025 | 19.23B | 36.66% |
| Dec 31, 2024 | 14.07B | 81.16% |
| Dec 29, 2023 | 7.77B | 17.12% |
| Dec 30, 2022 | 6.63B | -8.70% |
| Dec 31, 2021 | 7.26B | -14.53% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Oct 28, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Zai Lab | 15.74B |
| TenNor Therapeutics (Suzhou) | 13.30B |
| TransThera Sciences (Nanjing) | 11.51B |
| Nanjing Leads Biolabs | 10.66B |
| GenFleet Therapeutics (Shanghai) | 10.63B |
| Ascletis Pharma | 10.52B |
| LongBio Pharma (Suzhou) | 10.39B |
| HBM Holdings | 9.74B |